|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.80 DKK | +0.51% |
|
+17.24% | -36.58% |
| 05:23am | After Euphoria, a Traffic Jam on the Multi-Billion Dollar Kilo-Highway |  |
| Jun. 11 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.19B | |||||
| 55.58B | |||||
| 43.47B | |||||
| 22.64B | - | ||||
| 20.96B | - | ||||
| 15.79B |
- Stock Market
- Stocks
- ZEAL Stock
- Charts Zealand Pharma A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
